Unity Biotechnology (UBX) Short Interest Ratio & Short Volume → With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (From Stocks News) (Ad) Free UBX Stock Alerts $1.47 -0.06 (-3.92%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Unity Biotechnology Short Interest DataCurrent Short Volume330,400 sharesPrevious Short Volume304,800 sharesChange Vs. Previous Month+8.40%Dollar Volume Sold Short$508,816.00Short Interest Ratio / Days to Cover3.8Last Record DateApril 30, 2024Outstanding Shares16,790,000 sharesFloat Size15,330,000 sharesShort Percent of Float2.16%Today's Trading Volume132,645 sharesAverage Trading Volume79,397 sharesToday's Volume Vs. Average167% Short Selling Unity Biotechnology ? Sign up to receive the latest short interest report for Unity Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatUBX Short Interest Over TimeUBX Days to Cover Over TimeUBX Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… Unity Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024330,400 shares $508,816.00 +8.4%2.2%3.8 $1.54 4/15/2024304,800 shares $457,200.00 -0.8%2.0%3.4 $1.50 3/31/2024307,200 shares $503,808.00 +5.4%2.0%3.4 $1.64 3/15/2024291,600 shares $437,400.00 +0.3%1.9%2.7 $1.50 2/29/2024290,600 shares $531,798.00 -9.2%1.9%2.6 $1.83 2/15/2024320,000 shares $636,800.00 +4.5%2.1%3.4 $1.99 Get the Latest News and Ratings for UBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unity Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024306,100 shares $529,553.00 -0.3%2.0%3.1 $1.73 1/15/2024307,100 shares $571,206.00 -21.4%2.0%3.2 $1.86 12/31/2023390,700 shares $754,051.00 -15.6%N/A0 $1.93 12/15/2023463,100 shares $791,901.00 -7.7%3.1%5.5 $1.71 11/30/2023501,900 shares $963,648.00 -12.3%3.8%6.9 $1.92 11/15/2023572,500 shares $1.05 million -11.9%4.3%9.1 $1.83 10/31/2023649,600 shares $1.29 million +3.0%4.9%12.8 $1.99 10/15/2023630,900 shares $1.10 million -6.0%4.8%10.3 $1.75 9/30/2023670,900 shares $1.61 million -2.8%5.1%9.7 $2.40 9/15/2023690,400 shares $1.76 million -6.0%5.2%6.6 $2.55 8/31/2023734,600 shares $1.95 million -2.6%5.6%5.9 $2.65 8/15/2023754,500 shares $1.97 million -4.9%5.7%4.6 $2.61 7/31/2023793,500 shares $2.20 million +5.6%6.2%4.3 $2.77 7/15/2023751,800 shares $2.29 million -11.6%5.8%3.4 $3.05 6/30/2023850,300 shares $2.17 million +4.7%6.6%3.1 $2.55 6/15/2023811,900 shares $2.58 million -4.7%6.3%1.9 $3.18 5/31/2023851,900 shares $2.56 million -10.5%6.6%2 $3.01 5/15/2023952,200 shares $2.73 million -17.2%7.4%2.3 $2.87 4/30/20231,150,000 shares $2.46 million -4.2%9.2%2.6 $2.14 4/15/20231,200,000 shares $2.35 million -2.4%9.7%2.7 $1.96 3/31/20231,230,000 shares $2.00 million +21.8%9.9%3 $1.63 3/15/20231,010,000 shares $4.19 million +6.4%8.2%4.1 $4.15 2/28/2023949,000 shares $4.27 million +4.9%7.9%4.1 $4.50 2/15/2023904,900 shares $3.92 million +18.8%7.5%3.8 $4.33 1/31/2023761,600 shares $3.52 million +19.6%5.6%2.9 $4.62 1/15/2023636,700 shares $2.73 million +16.5%4.6%0.9 $4.29 12/30/2022546,500 shares $1.50 million -0.1%4.0%0.8 $2.74 12/15/2022547,000 shares $1.53 million -26.2%4.0%0.8 $2.79 11/30/2022740,900 shares $2.04 million -9.7%5.4%1.1 $2.75 11/15/2022820,100 shares $2.15 million +333.2%6.5%1.2 $2.62 10/31/2022189,300 shares $541,398.00 +68.3%1.5%0.2 $2.86 10/15/2022112,500 shares $441,000.00 -91.4%0.9%0.3 $3.92 9/30/20221,310,000 shares $517,581.00 -10.9%N/A0.3 $0.40 9/15/20221,470,000 shares $707,070.00 -17.0%N/A0.4 $0.48[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. UBX Short Interest - Frequently Asked Questions What is Unity Biotechnology's current short interest? Short interest is the volume of Unity Biotechnology shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 330,400 shares of UBX short. 2.16% of Unity Biotechnology's shares are currently sold short. Learn More on Unity Biotechnology's current short interest. What is a good short interest ratio for Unity Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UBX shares currently have a short interest ratio of 4.0. Learn More on Unity Biotechnology's short interest ratio. What is a good short interest percentage for Unity Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.16% of Unity Biotechnology's floating shares are currently sold short. Is Unity Biotechnology's short interest increasing or decreasing? Unity Biotechnology saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 330,400 shares, an increase of 8.4% from the previous total of 304,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Unity Biotechnology's float size? Unity Biotechnology currently has issued a total of 16,790,000 shares. Some of Unity Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Unity Biotechnology currently has a public float of 15,330,000 shares. How does Unity Biotechnology's short interest compare to its competitors? 2.16% of Unity Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Unity Biotechnology: Oncternal Therapeutics, Inc. (0.49%), Acasti Pharma Inc. (0.02%), Biora Therapeutics, Inc. (4.52%), JanOne Inc. (2.00%), Iterum Therapeutics plc (7.68%), Forte Biosciences, Inc. (0.08%), Lisata Therapeutics, Inc. (0.22%), RenovoRx, Inc. (0.19%), Enlivex Therapeutics Ltd. (1.42%), Aptorum Group Limited (0.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Unity Biotechnology stock? Short selling UBX is an investing strategy that aims to generate trading profit from Unity Biotechnology as its price is falling. UBX shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Unity Biotechnology? A short squeeze for Unity Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UBX, which in turn drives the price of the stock up even further. How often is Unity Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UBX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Oncternal Therapeutics Short Squeeze Acasti Pharma Short Squeeze Biora Therapeutics Short Squeeze JanOne Short Squeeze Iterum Therapeutics Short Squeeze Forte Biosciences Short Squeeze Lisata Therapeutics Short Squeeze RenovoRx Short Squeeze Enlivex Therapeutics Short Squeeze Aptorum Group Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UBX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHow Biden has already won 2024Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsWhy Is Gold On a MASSIVE rally? Huge AlertsAmericans Now Need $1.46M to Retire…Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingUrgent Nvidia WarningAltimetry